Document Classification

Section Type: RESULTS

Text: At endpoint, compared with montelukast, FSC significantly increased morning predose forced expiratory volume in 1 second (0. 61 + / - 0. 03 L vs 0. 32 + / - 0. 03 L), morning peak expiratory flow rate (peak expiratory flow rate ; 81. 4 + / - 5. 9 L/minute vs 41. 9 + / - 4. 8 L/minute), evening peak expiratory flow rate (64. 6 + / - 5. 3 L/minute vs 38. 8 + / - 4. 7 L/minute), the percentage of symptom-free days (40. 3 + / - 2. 9 % vs 27. 0 + / - 2. 7 %), the percentage of rescue-free days (53. 4 + / - 2. 8 % vs 26. 7 + / - 2. 5 %), and the percentage of nights with no awakenings (29. 8 + / - 2. 5 % vs 19. 6 + / - 2. 1 %) (P < or = 0. 011, all comparisons).